The Life Science industry has been in the grasps of a reproducibility emergency for various years.
Abcam is driving the way in tending to this with our scope of recombinant monoclonal antibodies and knockout altered cell lines for highest quality level approval.
Kindly check that this item addresses your issues prior to buying.The NS1 protein is a significant non-strucutural protein communicated by t he Zika Virus. The NS1 monomer is a glycosylated protein of around 45kD, which partners with lipids and structures a homodimer inside contaminated cells.
It is essential for viral replication, and is additionally emitted into the extracellular space as a hexameric lipoprotein molecule, which is associated with invulnerable avoidance and pathogenesis by collaborating with parts from both the inborn and versatile resistant frameworks, as well as other host factors. NS1 is one of the major antigenic markers for viral contamination with Zika.
Zika infection is an arising sickness that is spread by Aedes mosquitoes. The infection was first detached in Central Africa, and has since spread to South Asia and all the more as of late to South America.
It is an individual from the flavivirus family, and is fundamentally firmly connected with infections like Dengue Fever Virus.Episodes were accounted for in Micronesia in 2007 and in Brazil in 2015, affirming somewhere around 13 autochthonous diseases. The Zika infection episode in Brazil in 2016 has acquired overall consideration, and has been connected to a rising number of microcephaly cases.
In April 2016 the Centers for Disease Control, in the USA, affirmed the connection between Zika infection contamination of the baby with microcephaly.
Clinically Zika infection can cause gentle fever, rash, myalgia, arthralgia and cerebral pains, with one of every four tainted people being asymptomatic. Because of comparative side effects Zika infection tainted people can undoubtedly be mis-analyzed as a dengue disease as well as the other way around.
What’s more, Zika infection has been embroiled in causing microcephaly through transmission in utero. There is no antibody or explicit treatment accessible for Zika infection.
Zika infection (ZIKV) is a RNA infection of the Flaviviridae family, and is basically near dengue and chikungunya infections. ZIKV can be sent by Aedes mosquitoes and sexual contact. The relationship of ZIKV contamination with microcephaly and neurological sicknesses has as of late featured a worldwide arising general wellbeing concern.
ZIKV NS1 (Non-Structural protein 1) is a glycoprotein that fills in as a significant host-cooperation particle that capacities in flaviviral replication, pathogenesis and invulnerable avoidance 1. The as of late tackled design of ZIKV NS1 has shown it has one of a kind surface attributes that can be taken advantage of in the advancement of novel analytic instruments for Zika contamination.
B7160 was created against recombinant Zika NS1 protein communicated from bug cells and cleaned from hybridoma cell culture by means of protein A partiality chromatography.
The huge T antigen (TAg) of Simian infection 40 goes about as an initiator of DNA replication, partakes in cell change, and incites cell development. Various utilitarian areas have been described including the N-terminal J space, atomic confinement signal (NLS), inside helicase area, Rb and topoisomerase I collaborating space, p53 and ATP restricting space.
The p53-collaborating space is additionally fundamental for restricting p300/CBP. Phosphorylation of TAg by a few kinases might control its capacity both decidedly and adversely.
The viral replication of simian infection 40 (SV40) is done by a solitary protein, T-antigen. This element makes the infection a helpful framework for figuring out the course of replication and to recognize the parts of replication apparatus.
It capacities as a DNA helicase alongside a cell single-strand DNA restricting protein and topoisomerase I or II, prompting broad beginning loosening up and development of a pre-commencement complex. The T-antigen partners with two growth silencer proteins, p53 and the retinoblastoma protein pRb, and inactivates them.
The enormous T antigen (TAg) of Simian infection 40 goes about as an initiator of DNA replication, takes an interest in cell change, and incites cell development. Various useful spaces have been described including the N-terminal J area, atomic restriction signal (NLS), inner helicase space, Rb and topoisomerase I collaborating area, p53 and ATP restricting space.
The p53-collaborating space is likewise fundamental for restricting p300/CBP. Phosphorylation of TAg by a few kinases might manage its capacity both decidedly and adversely.
The viral replication of simian infection 40 (SV40) is done by a solitary protein, T-antigen. This element makes the infection a valuable framework for grasping the course of replication and to distinguish the parts of replication apparatus.
Zika Virus NS1 Recombinant Protein | ||||
| 97-074 | ProSci | 0.05 mg | 752.1 EUR | |
Recombinant Zika Virus NS1 protein | ||||
| DAGA-038 | Creative Diagnostics | 1 mg | 1714.8 EUR | |
Recombinant Zika Virus NS1 protein | ||||
| DAGA-046 | Creative Diagnostics | 100 µg | 774 EUR | |
Recombinant Zika virus NS1 Protein | ||||
| P1064-10 | Biovision | each | 189.6 EUR | |
Recombinant Zika virus NS1 Protein | ||||
| P1064-50 | Biovision | each | 366 EUR | |
Zika virus NS1/Env. recombinant antigen | ||||
| 8827 | Virostat | 100 ug | 673.36 EUR | |
Recombinant Zika Virus NS1 Protein (Biotin) | ||||
| VAng-Lsx0576-inquire | Creative Biolabs | inquire | Ask for price | |
Recombinant Zika Virus NS1 Protein (Insect cells) | ||||
| VAng-Lsx0577-100g | Creative Biolabs | 100 µg | 1365.6 EUR | |
Human Zika Virus NS1 Recombinant Protein His Tag Lyophilized | ||||
| IHUZIKANS1RHISLY50UG | Innovative research | each | 899 EUR | |
Recombinant Zika Virus NS1 Protein (aa 805-1147) (E. coli) | ||||
| VAng-Lsx0578-100g | Creative Biolabs | 100 µg | 712.8 EUR | |
Recombinant Zika Virus NS1 Protein (aa 805-1147) (293 cells) | ||||
| VAng-Lsx0579-100g | Creative Biolabs | 100 µg | 1210.8 EUR | |
Recombinant (E. coli) Zika Virus NS1 Protein (African) control for Western blot | ||||
| ZNS111-C | Alpha Diagnostics | 100 ul | 343.2 EUR | |
Zika Virus NS1 antigen | ||||
| 00346-V-01mg | Virogen | 0,1 mg | 321 EUR | |
Zika Virus NS1 antigen | ||||
| 00346-V-1000ug | Virogen | 1000 ug | 1539 EUR | |
Zika virus NS1 protein | ||||
| 30-1931 | Fitzgerald | 100 ug | 613.2 EUR | |
Zika virus NS1 protein | ||||
| 30-1936 | Fitzgerald | 100 ug | 289.2 EUR | |
Zika Virus NS1 Protein | ||||
| abx061380-1mg | Abbexa | 1 mg | 1722 EUR | |
Zika virus NS1 antibody | ||||
| 10-2707 | Fitzgerald | 1 mg | 678 EUR | |
Zika virus NS1 antibody | ||||
| 10-2708 | Fitzgerald | 1 mg | 678 EUR | |
Zika virus NS1 antibody | ||||
| 10-2709 | Fitzgerald | 1 mg | 678 EUR | |
Zika virus NS1 antibody | ||||
| 10-2710 | Fitzgerald | 1 mg | 678 EUR | |
Zika virus NS1 antibody | ||||
| 10-2711 | Fitzgerald | 1 mg | 678 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024134-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024135-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024136-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024137-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024138-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024139-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024140-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024141-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024142-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024143-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024144-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024159-1mg | Abbexa | 1 mg | 727.2 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024160-1mg | Abbexa | 1 mg | 1212 EUR | |
Zika virus NS1 antibody | ||||
| 70-1086 | Fitzgerald | 500ug | 366 EUR | |
Zika virus NS1 antibody | ||||
| 70-1087 | Fitzgerald | 500 ug | 638.4 EUR | |
Recombinant Zika Virus E Protein | ||||
| VAng-Lsx0581-100g | Creative Biolabs | 100 µg | 1365.6 EUR | |
Zika virus Envelope recombinant antigen | ||||
| 8826 | Virostat | 100 ug | 673.36 EUR | |
Recombinant Zika Virus Envelope protein | ||||
| DAGA-048 | Creative Diagnostics | 100 µg | 774 EUR | |
Recombinant Zika Virus Envelope protein | ||||
| DAGA6128 | Creative Diagnostics | 2UG | 624 EUR | |
Recombinant (Sf9) Zika Virus NS1 Protein (African, full length, >95%, His-tag) for ELISA/Western | ||||
| ZNS117-R-10 | Alpha Diagnostics | 10 ug | 416.4 EUR | |
Recombinant (Sf9) Zika Virus NS1 Protein (African, full length, >95%, His-tag) for ELISA/Western | ||||
| ZNS117-R-100 | Alpha Diagnostics | 100 ug | 1365.6 EUR | |
Recombinant Zika NS1 Protein, His, E.coli-1mg | ||||
| QP14001-HIS-1mg | EnQuireBio | 1mg | 1513.2 EUR | |
Recombinant Zika Virus Capsid Protein (Uganda) | ||||
| VAng-Lsx0585-100g | Creative Biolabs | 100 µg | 720 EUR | |
Recombinant Zika Virus Capsid Protein (Uganda) | ||||
| VAng-Lsx0585-1mg | Creative Biolabs | 1 mg | 3688.8 EUR | |
Recombinant Zika Virus E Protein (Domain III) | ||||
| VAng-Lsx0583-inquire | Creative Biolabs | inquire | Ask for price | |
Zika Virus NS1 antigen 34 kDa | ||||
| 00346-V-100ugvial | Virogen | 100 ug/vial | 150 EUR | |
Recombinant Zika Virus Capsid Protein (Brazil) [His] | ||||
| VAng-Lsx0584-100g | Creative Biolabs | 100 µg | 720 EUR | |
Recombinant Zika Virus Capsid Protein (Brazil) [His] | ||||
| VAng-Lsx0584-1mg | Creative Biolabs | 1 mg | 3688.8 EUR | |
Mouse antibody for Zika virus NS1 | ||||
| 5122 | Virostat | 100 ug | 405.83 EUR | |
Mouse antibody for Zika virus NS1 | ||||
| 5123 | Virostat | 100 ug | 405.83 EUR | |
Mouse antibody for Zika virus NS1 | ||||
| 5124 | Virostat | 100 ug | 405.83 EUR | |
Mouse antibody for Zika virus NS1 | ||||
| 5125 | Virostat | 100 ug | 405.83 EUR | |
Recombinant (HEK) Zika Virus NS1 Protein (Brazil, full length, >95%, His-tag, low endotoxin) for ELISA/Western | ||||
| ZNS118-R-10 | Alpha Diagnostics | 10 ug | 416.4 EUR | |
Recombinant (HEK) Zika Virus NS1 Protein (Brazil, full length, >95%, His-tag, low endotoxin) for ELISA/Western | ||||
| ZNS118-R-100 | Alpha Diagnostics | 100 ug | 1365.6 EUR | |
Human CellExp? Zika virus NS1 Protein | ||||
| P1062-10 | Biovision | each | 314.4 EUR | |
Recombinant (E. coli) Zika Virus NS1 Protein (African, full length, 795-1148 aa, >95%, His-tag) for ELISA/Western | ||||
| ZNS115-R-10 | Alpha Diagnostics | 10 ug | 416.4 EUR | |
Recombinant (E. coli) Zika Virus NS1 Protein (African, full length, 795-1148 aa, >95%, His-tag) for ELISA/Western | ||||
| ZNS115-R-100 | Alpha Diagnostics | 100 ug | Ask for price | |
Recombinant Zika Virus E Protein (aa 291-700) [His] | ||||
| VAng-Lsx0580-100g | Creative Biolabs | 100 µg | 712.8 EUR | |
Zika NS1 Protein Recombinant Protein | ||||
| PROTB5AHE9 | BosterBio | Regular: 0.5mg | 945.6 EUR | |
Recombinant Zika Virus PreM Protein (Brazil) (aa 126-259) [His] | ||||
| VAng-Lsx0582-100g | Creative Biolabs | 100 µg | 720 EUR | |
Recombinant Zika Virus PreM Protein (Brazil) (aa 126-259) [His] | ||||
| VAng-Lsx0582-1mg | Creative Biolabs | 1 mg | 3688.8 EUR | |
Zika Virus ENV -NS1 fusion antigen 54 kDa | ||||
| 00345-V-100ugvial | Virogen | 100 ug/vial | 150 EUR | |
Recombinant Zika NS1 Protein, His, E.coli-2ug | ||||
| QP14001-HIS-2ug | EnQuireBio | 2ug | 186 EUR | |
Recombinant Zika NS1 Protein, His, E.coli-10ug | ||||
| QP14001-HIS-10ug | EnQuireBio | 10ug | 241.2 EUR | |
Recombinant Zika NS1 Protein, His, E.coli-50ug | ||||
| QP14001-HIS-50ug | EnQuireBio | 50ug | 654 EUR | |
Recombinant Zika NS1 Protein, His, E.coli-100ug | ||||
| QP14001-HIS-100ug | EnQuireBio | 100ug | 261.6 EUR | |
Recombinant Zika NS1 Protein, His, E.coli-500ug | ||||
| QP14001-HIS-500ug | EnQuireBio | 500ug | 795.6 EUR | |
Recombinant Zika NS1 Protein, His, Insect-2ug | ||||
| QP14001-HIS-INSECT-2ug | EnQuireBio | 2ug | 186 EUR | |
Recombinant Dengue Virus NS1 Type 2 | ||||
| 7-08032 | CHI Scientific | 100µg | Ask for price | |
Recombinant Dengue Virus NS1 Type 2 | ||||
| 7-08033 | CHI Scientific | 500µg | Ask for price | |
Recombinant Dengue Virus NS1 Type 2 | ||||
| 7-08034 | CHI Scientific | 1000µg | Ask for price | |
Recombinant Zika NS1 Protein, His, Insect-10ug | ||||
| QP14001-HIS-INSECT-10ug | EnQuireBio | 10ug | 241.2 EUR | |
Recombinant Zika NS1 Protein, His, Insect-50ug | ||||
| QP14001-HIS-INSECT-50ug | EnQuireBio | 50ug | 654 EUR | |
Zika Virus ENV-NS1 fusion antigen | ||||
| 00345-V-01mg | Virogen | 0,1 mg | 321 EUR | |
Zika Virus ENV-NS1 fusion antigen | ||||
| 00345-V-1000ug | Virogen | 1000 ug | 1539 EUR | |
Recombinant Dengue Virus Dengue NS1 Protein, His, E.coli-1mg | ||||
| QP11641-1mg | EnQuireBio | 1mg | 1513.2 EUR | |
Recombinant Dengue Virus NS1 Subtype 1 | ||||
| 7-08041 | CHI Scientific | 100µg | Ask for price | |
Recombinant Dengue Virus NS1 Subtype 1 | ||||
| 7-08042 | CHI Scientific | 500µg | Ask for price | |
Recombinant Dengue Virus NS1 Subtype 1 | ||||
| 7-08043 | CHI Scientific | 1000µg | Ask for price | |
Recombinant Dengue Virus NS1 Subtype 3 | ||||
| 7-08044 | CHI Scientific | 100µg | Ask for price | |
Recombinant Dengue Virus NS1 Subtype 3 | ||||
| 7-08045 | CHI Scientific | 500µg | Ask for price | |
Recombinant Dengue Virus NS1 Subtype 3 | ||||
| 7-08046 | CHI Scientific | 1000µg | Ask for price | |
Recombinant Dengue Virus NS1 Subtype 4 | ||||
| 7-08047 | CHI Scientific | 100µg | Ask for price | |
Recombinant Dengue Virus NS1 Subtype 4 | ||||
| 7-08048 | CHI Scientific | 500µg | Ask for price | |
Recombinant Dengue Virus NS1 Subtype 4 | ||||
| 7-08049 | CHI Scientific | 1000µg | Ask for price | |
Recomb. (Sf9) Zika Virus NS1 Protein (African, full length, >95%, His-tag) for ELISA | ||||
| ZNS117-R-BTN | Alpha Diagnostics | 10 ug | 634.8 EUR | |
Recombinant Zika Virus Envelop domain III (African) control for Western blot | ||||
| ZEND21-C | Alpha Diagnostics | 100 ul | 343.2 EUR | |
Recombinant Dengue Virus Dengue NS1 n Protein, GST, E.coli-1mg | ||||
| QP11643-1mg | EnQuireBio | 1mg | 1273.2 EUR | |
Recombinant Dengue Virus, ST1 Dengue NS1 Protein, His, E.coli-1mg | ||||
| QP10495-1mg | EnQuireBio | 1mg | 1513.2 EUR | |
Recombinant Dengue Virus, ST3 Dengue NS1 Protein, His, E.coli-1mg | ||||
| QP104961-1mg | EnQuireBio | 1mg | 1513.2 EUR | |
It capacities as a DNA helicase alongside a cell single-strand DNA restricting protein and topoisomerase I or II, prompting broad beginning loosening up and arrangement of a pre-inception complex. The T-antigen partners with two cancer silencer proteins, p53 and the retinoblastoma protein pRb, and inactivates them.